PROSTATE CANCER METASTATIC DISEASE
Clinical trials for PROSTATE CANCER METASTATIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER METASTATIC DISEASE trials appear
Sign up with your email to follow new studies for PROSTATE CANCER METASTATIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat prostate cancer: experimental drug HLD-0915 enters human trials
Disease control Recruiting nowThis early-stage study tests an experimental drug called HLD-0915 in men with metastatic castration-resistant prostate cancer (mCRPC) whose cancer has worsened despite standard treatments. The study has two parts: first, finding a safe dose, then testing how well that dose works.…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Halda Therapeutics OpCo, Inc. • Aim: Disease control
Last updated May 20, 2026 11:58 UTC
-
New Scan-Guided combo therapy aims to slow prostate cancer spread
Disease control Recruiting nowThis study is for men with metastatic hormone-sensitive prostate cancer (mHSPC) whose cancer still shows active spots on a special PET scan after 8 months of hormone therapy. It tests whether adding targeted local treatment (like radiation) to continued hormone therapy can delay …
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 19, 2026 11:50 UTC
-
Diet and exercise may cut heart risks for men on prostate cancer therapy
Disease control Recruiting nowThis study looks at whether a calorie-controlled, anti-inflammatory diet combined with walking can reduce heart disease risk factors in men with advanced prostate cancer who are on hormone therapy (ADT). The researchers want to see if African American men respond differently than…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New scan could spot hidden prostate cancer spread
Diagnosis Recruiting nowThis study tests a new imaging method called FAPI PET/MRI to see if it can find prostate cancer tumors better than current scans. About 30 adults with prostate cancer will get two research scans. The goal is to improve how doctors detect and track the disease.
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated May 26, 2026 03:05 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden prostate cancer
Diagnosis Recruiting nowThis study tests a special dye called OTL78 that makes prostate cancer cells glow during surgery. The goal is to help surgeons find and remove cancer that might otherwise be missed. About 22 men with aggressive prostate cancer will take part. The dye is given before surgery and a…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Clinton Bahler • Aim: Diagnosis
Last updated May 26, 2026 03:05 UTC
-
New hope for Men's hot flashes: drug targets sweaty side effect of prostate cancer treatment
Symptom relief Recruiting nowThis study tests a drug called fezolinetant to see if it can reduce hot flashes in men with prostate cancer who are on hormone therapy (ADT). About 60 men will take either the drug or a placebo daily for 4 weeks. Researchers will track hot flash frequency, severity, and any liver…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated May 26, 2026 03:10 UTC
-
New scan combo aims to catch returning prostate cancer earlier
Knowledge-focused Recruiting nowThis study looks at whether adding a PSMA PET scan to the usual MRI scan can better find prostate cancer that has come back after focal therapy (a treatment that targets only the tumor). About 62 men who have had focal therapy will get both scans. The goal is to see if the PSMA P…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC
-
Lab-Grown Mini-Tumors could personalize prostate cancer care
Knowledge-focused Recruiting nowThis study aims to improve how doctors choose treatments for aggressive prostate cancer. Researchers will grow 3D mini-tumors from patient samples and test different therapies on them to see which works best. The goal is to find the most effective lab technique for predicting ind…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated May 18, 2026 11:58 UTC
-
New scan could save time and money for prostate cancer patients
Knowledge-focused Recruiting nowThis study looks at whether a type of scan called SPECT/CT can help doctors see if treatment is working in men with advanced prostate cancer. The treatment uses a radioactive drug (Lu-177 PSMA) that targets cancer cells. Researchers want to see if SPECT/CT, which is cheaper and m…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC